Friday, 17 April 2015

Defective medicine


17 April 2015
                I reminded prices in medicine, that the Moffitt cancer centre had used high intensity ultrasound to cure prostate cancer in 2002: this works for all cancers-which share a non native inflated cell structure.  In order to divide and grow.
                So all research and teaching of biochemical treatments was defective medicine prohibited by the Hippocratic oath.  Today I read a newspaper item on a new biochemical test, which would predict the development of breast cancer within five years.
                Use of a 5 W 1 MHz ultrasonic massage device to the chest, throat and nose for just ½ minute will stop the development of all cancers, heart disease and diabetes.
                So the test is to predict the demand of cancer is obviously superfluous!  Once again prohibited defective medicine.  High Intensity UltraSound will stop the development of all cancers.  People are not remotely interested in testing for a cancer which will never develop.
                Any cancer is routinely cures using ½ minutes external application of HIUS.  Professors of medicine have a bigger problem.  They are the register Dr.!  So are prohibited from research into defective medicine.
                Yet they have committed to research biochemical treatments since the development of HIUS in 2002.  They are no longer register doctors!  And must return all salary paid to them since the violated the Hippocratic oath.
                The evidence that they violated the Hippocratic oath, has been printed angrily disseminated.  Only one paper on biochemical treatments removes them from the health sector permanently.
                The same argument applies to all register doctors and hospital consultants.  Copy this e-mail to every registered Dr. you know.  Alone to continue in medical practice is massive medical malpractice.  The lawyers can take it from here.
                No proprietary antibody development is permitted.

Jonathan Thomason       JonThm9@aol.com

No comments: